Healthcare Pharmaceutical Biotech

SynAct Pharma Signs First Commercial Partnership for Resomelagon with Leading Brazilian Pharmaceutical Company

October 27, 2026 10:12 AM

SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announced that it has entered into a strategic co-development and commercialization agreement with Hipolabor Farmacêutica LTDA ("Hipolabor") for resomelagon in the treatment of dengue in Brazil, one of the world's largest markets for dengue...

Read more

Who Is the Best FTM Top Surgeon in the World?

October 27, 2026 10:00 AM

For transgender men and non-binary patients researching who the best FTM top surgeon is, one name appears again and again: Dr. Javad Sajan of Allure Esthetic in Seattle, Washington. With more than 4,000 FTM top surgeries performed, a signature 3D chest-sculpting technique, a drain-free recovery protocol, nerve-preserving neurorrhaphy to restore nipple sensation, no BMI limits for qualified candidates, and acceptance of all private insurances,...

Read more

As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides

October 27, 2026 9:15 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, explained today that the Phase IIA Ebola Treatment Clinical Trial of NV-387 Oral Gummies is progressing well, and the drug is expected to advance into the Phase IIB clinical trial part as soon as the Phase IIA part is completed. "The importance of the NV-387 Oral Gummies treatment for this Ebola Bundibugyo...

Read more

CRIO and Eli Lilly and Company win SCDM Innovation Award for Alzheimer's trial

October 27, 2026 9:00 AM

CRIO, the leading provider of eSource technology for clinical research, received an SCDM Innovation Award with Eli Lilly and Company in the Clinical Data Science Implementation Excellence category at the SCDM 2026 Annual Conference. The awards program recognizes organizations that excel at integrating clinical data science through people, processes and technology. CRIO and Lilly were recognized for their collaboration on a global Phase 3...

Read more

Kratom and 7-OH Now Half of QuickMD's New Addiction Patients, Up 5x as Federal Restrictions Loom

October 27, 2026 9:00 AM

QuickMD, the largest U.S. telemedicine provider of opioid use disorder care, today released new data showing a dramatic surge in new patients seeking treatment for kratom and 7-OH dependence. These substances now account for half of QuickMD's new addiction treatment patients, a 5x increase from 10% in 2024 to 50% by August 2026. The findings come from a new QuickMD report, Kratom & 7-OH: An Emerging Treatment Population, based on aggregated,...

Read more

Genomate and VivaMed to Rescue and Repurpose Oncology Drugs with AI and Clinical Data

October 27, 2026 8:12 AM

Genomate Health, a precision oncology company, today announced a strategic partnership with VivaMed BioPharma to advance existing drugs and promising compounds for new applications in cancer based on the underlying molecular interactions of the tumor. Together, they aim to build the computational and clinical evidence needed to bring these treatments to market for the patients most likely to benefit. Progress in cancer treatment remains uneven....

Read more

Duly Health and Care Announces Acquisition of Fox Valley Imaging

October 27, 2026 8:00 AM

Duly Health and Care announced today the acquisition of Fox Valley Imaging, an independent diagnostic imaging center serving Naperville and surrounding communities for more than 30 years. The acquisition expands Duly's outpatient imaging network and advances its commitment to making high-quality healthcare more accessible, affordable and convenient for patients across Chicago's western suburbs. Located at 1971 Gowdey Road in Naperville, Fox...

Read more

Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026

October 27, 2026 7:00 AM

Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that senior management will participate in four investment bank conferences taking place in November 2026. 8th Annual Wolfe Research Healthcare Conference Format: Fireside Chat and 1x1 meetings Date: Tuesday, November 10, 2026 Time: 1:20 - 1:50 p.m. EST Location: New York, NY Truist Securities 2026 Biopharma Symposium Format: 1x1 meetings Date: Thursday,...

Read more

Cantargia to Present at the Stifel 2026 Healthcare Conference

October 27, 2026 4:20 AM

Cantargia AB (publ) (NASDAQ Stockholm:CANTA) today announced that representatives from the company's executive management will hold a company presentation and participate in investor meetings at the Stifel 2026 Healthcare Conference in New York, November 10, 2026. Location: Lotte NY Palace, New York Format: Company Presentation by Hilde Steineger, CEO Date and Time: Tuesday November 10 at 9:20 - 9:50 AM ET (3:20 - 3:50 PM CET) Webcast: Link to...

Read more

YMC America Connects Chromatography Customers with Published Research Through Bioz Badges

October 27, 2026 4:00 AM

Bioz, Inc., a scientific intelligence platform that uses citation data to show how products are used in published research, has been selected by YMC America, a provider of chromatography products and purification technologies, to bring publication-backed evidence to its website through Bioz Badges. The integration gives scientists immediate access to relevant research publications as they evaluate YMC products for their separation and...

Read more

The U.S. Patent and Trademark Office Has Issued a Notice of Allowance for A Patent Covering IRLAB's Drug Candidate IRL1117

October 27, 2026 2:20 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, today announced that the U.S. Patent and Trademark Office (USPTO) intends to grant a patent for IRL1117, a drug candidate with the potential to revolutionize the treatment of the core symptoms of Parkinson's disease. The patent is expected to remain in force until the early 2040s. The U.S. Patent and Trademark...

Read more

Marvin Smoot Named Chief Executive Officer of Missouri Valley Regional Medical Center

October 26, 2026 4:45 PM

Missouri Valley Regional Medical Center (MVRMC) is pleased to announce the appointment of Marvin Smoot as Chief Executive Officer. Smoot brings more than 20 years of healthcare leadership experience and a proven record of strengthening hospital operations, improving financial performance, expanding access to care and advancing long-term organizational growth. Throughout his career, he has served in senior leadership roles with leading healthcare...

Read more

Cenmed Establishes Strategic Presence at HELIX as Company Enters Next Phase of Growth

October 26, 2026 3:40 PM

Cenmed Enterprises, a New Brunswick-based healthcare and life sciences company, today announced that it is establishing a strategic presence at HELIX, marking another step in the company's evolution from a traditional medical and laboratory distributor into a broader, technology-enabled partner to healthcare, research and life sciences organizations. The move brings Cenmed into one of New Jersey's emerging centers for healthcare, research,...

Read more

Aspira Plastic Surgery & Med Spa Offers Savings on Liposuction and Complimentary Consultations

October 26, 2026 12:00 PM

Aspira Plastic Surgery & Med Spa is offering fall savings on two laser-assisted liposuction procedures performed in its Austin office. From October 1 through November 30, the practice is taking $1,000 off SmartLipo procedures that include a minimum of three treatment areas and $500 off chin and jawline liposuction. Complimentary consultations are available through December 31. Board-certified plastic surgeon Dr. Venkata Erella performs both...

Read more

Pepti Announces Launch of HelloPepti.com, a Digital Telehealth Platform

October 26, 2026 11:00 AM

Pepti LLC announced the launch of HelloPepti.com, a U.S. digital telehealth platform specializing in the coordination of physician-guided evaluations involving peptide-related medicine. The platform began its initial rollout in September 2026. Its introduction marks the company's entry into the specialized telehealth technology sector. Company Background Pepti was founded in 2026 to develop digital infrastructure for a specialized segment of the...

Read more

AGFA HealthCare Selected by Infirmary Health to Modernize Imaging Across Its Health System

October 26, 2026 11:00 AM

Infirmary Health has selected AGFA HealthCare Enterprise Imaging Cloud (SaaS) to modernize its radiology imaging environment and establish a foundation for a broader Enterprise Imaging strategy across the health system. The fully managed SaaS solution will initially support radiology and mammography, bringing together diagnostic imaging, intelligent workflow orchestration, vendor-neutral image management and integration with Infirmary Health's...

Read more

A Turning Point: A Kidney Diagnosis Leads to a Path Toward Healing

October 26, 2026 10:10 AM

"Learning I had kidney disease was a big turning point," Nobert Mike remembers. Nobert shares that he had a hard life growing up: "I lost a lot of good people, lost a lot of good things in my life." He, like many other people he knows living on Navajo Nation, struggled with alcohol addiction. Eventually, his experience with addiction led to health complications. He was in the hospital for a week when test results confirmed his diagnosis, stage 3...

Read more

Dragonfleye Therapeutics Corp. Takes Flight, Raising US$37.5 Million in Private Placement Offerings to Advance Novel Ocular Platform-Based Treatments

October 26, 2026 10:00 AM

Dragonfleye Therapeutics Corp. ("Dragonfleye" or the "Company"), a patient-centered, innovation-focused company developing minimally invasive treatments for pathologic conditions in ophthalmology using its platform technology, today announced that it completed two non-brokered private placements of common shares during 2026, raising aggregate gross proceeds of US$37.5 million (the "Offerings"). Participants included healthcare-dedicated...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Subsidiary Real Game Used Maintains Steady Authentication Backlog

October 26, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that its subsidiary Real Game Used continues to operate with a steady backlog of customer-initiated authentication submissions and authentication work for auction brands. Real Game Used (https://realgameused.com) recently launched an automated submission system on its website, allowing customers to initiate authentication requests online. The platform currently carries a continuous...

Read more

Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant

October 26, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced that ten patients with newly diagnosed acute myeloid leukemia (AML) have advanced to allogeneic stem cell transplant following treatment with mipletamig in combination with venetoclax and azacitidine. Stem cell transplant uses donor cells to replace a patient's blood-forming stem cells and...

Read more